Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL29103842 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL24748 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437096 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL599527 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL607698 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL12865302 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL3552086 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437099 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL606328 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL851320 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584275-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | Halda Therapeutics Opco, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054604-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-2925738-B1 | CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF | GFBIOCHEMICALS LTD (MT) | 2018-01-10 | — | — | EP | disclosed |
| US-9458414-B2 | Cleaning, surfactant, and personal care compositions | GFBIOCHEMICALS LIMITED (MT) | 2016-10-04 | — | — | US | disclosed |
| US-9156809-B2 | Carboxy ester ketals, methods of manufacture, and uses thereof | SEGETIS, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| EP-2925738-A1 | CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF | Segetis, Inc. (US) | 2015-10-07 | — | — | EP | disclosed |
| US-20150252302-A1 | CLEANING, SURFACTANT, AND PERSONAL CARE COMPOSITIONS | SEGETIS, INC. (US) | 2015-09-10 | — | — | US | disclosed |
| US-8828917-B2 | Carboxy ester ketal removal compositions, methods of manufacture, and uses thereof | SEGETIS, INC. (US) | 2014-09-09 | — | — | US | disclosed |
| WO-2014085609-A1 | CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF | SEGETIS, INC. (US) | 2014-06-05 | — | — | WO | disclosed |
| US-20140147395-A1 | CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF | SEGETIS, INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-6887837-B2 | Water-based paint-removing solution | HENKEL KOMMANDIRGESELLSCHAFT AUF AKTIEN (DE) | 2005-05-03 | — | — | US | disclosed |
| US-20040259753-A1 | Water-based flushing solution for paints and other coatings | HENKEL AG & CO. KGAA (DE) | 2004-12-23 | — | — | US | disclosed |
| US-20040127375-A1 | Coating removal compositions | HENKEL AG & CO. KGAA (DE) | 2004-07-01 | — | — | US | disclosed |
| WO-2004047871-A2 | MODIFIED NATURETIC COMPOUNDS, CONJUGATES, AND USES THEREOF | NOBEX CORPORATION (US) | 2004-06-10 | — | — | WO | disclosed |
| US-20040084373-A1 | Adding chemical(s) to treatment vessel; separating aggregated compounds; directing to sprayer; solution contains amine and/or alkanolamine, polyoxypropylene glyocl, alkoxyethanol, and water | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-05-06 | — | — | US | disclosed |
| EP-1375606-A2 | Flushing solutions for coatings removal | Henkel KGaA (DE) | 2004-01-02 | — | — | EP | disclosed |
| US-20040002437-A1 | Flushing solutions for coatings removal | HENKEL AG & CO. KGAA (DE) | 2004-01-01 | — | — | US | disclosed |
| EP-1348042-A1 | WATER-BASED PAINT-REMOVING SOLUTION | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-10-01 | — | — | EP | disclosed |
| US-20020144718-A1 | Water-based paint-removing solution | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-10-10 | — | — | US | disclosed |
| WO-2002053802-A1 | WATER-BASED PAINT-REMOVING SOLUTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140147395-A1 | CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF | C9, C5, C1S | TSHR 3990/4885NAAA 1496/4885KDM4E 65/4885 |
| US-20150252302-A1 | CLEANING, SURFACTANT, AND PERSONAL CARE COMPOSITIONS | ADH1C, C5, KAT7 | TSHR 1209/4885NAAA 2852/4885KDM4E 1737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.